Ronggui Hu

2.6k total citations
32 papers, 1.5k citations indexed

About

Ronggui Hu is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Ronggui Hu has authored 32 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 11 papers in Oncology and 6 papers in Genetics. Recurrent topics in Ronggui Hu's work include Ubiquitin and proteasome pathways (12 papers), Peptidase Inhibition and Analysis (4 papers) and Cancer-related Molecular Pathways (4 papers). Ronggui Hu is often cited by papers focused on Ubiquitin and proteasome pathways (12 papers), Peptidase Inhibition and Analysis (4 papers) and Cancer-related Molecular Pathways (4 papers). Ronggui Hu collaborates with scholars based in China, United States and Germany. Ronggui Hu's co-authors include Alexander Varshavsky, Jun Sheng, Yong Tae Kwon, Ilia V. Davydov, Terry T. Takahashi, Zhenming Xu, Xin Qi, Jee Young An, Anna Kashina and Fangyong Du and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Ronggui Hu

32 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ronggui Hu China 19 1.0k 474 179 173 160 32 1.5k
Su-Jung Park United States 20 719 0.7× 276 0.6× 136 0.8× 99 0.6× 160 1.0× 25 1.1k
Beat Bornhäuser Switzerland 24 1.2k 1.1× 343 0.7× 249 1.4× 116 0.7× 173 1.1× 63 1.9k
Pierre Close Belgium 24 1.5k 1.4× 305 0.6× 200 1.1× 113 0.7× 355 2.2× 44 2.0k
M. Papathanasiou Greece 7 719 0.7× 290 0.6× 66 0.4× 92 0.5× 176 1.1× 17 1.2k
Mei Zhao China 26 1.1k 1.1× 294 0.6× 151 0.8× 111 0.6× 595 3.7× 62 1.7k
Tamás I. Orbán Hungary 21 964 0.9× 301 0.6× 103 0.6× 140 0.8× 226 1.4× 59 1.4k
Vivian Gama United States 22 892 0.9× 202 0.4× 135 0.8× 86 0.5× 106 0.7× 51 1.3k
Hitoki Hasegawa Japan 18 633 0.6× 289 0.6× 155 0.9× 230 1.3× 177 1.1× 32 1.1k

Countries citing papers authored by Ronggui Hu

Since Specialization
Citations

This map shows the geographic impact of Ronggui Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ronggui Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ronggui Hu more than expected).

Fields of papers citing papers by Ronggui Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ronggui Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ronggui Hu. The network helps show where Ronggui Hu may publish in the future.

Co-authorship network of co-authors of Ronggui Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Ronggui Hu. A scholar is included among the top collaborators of Ronggui Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ronggui Hu. Ronggui Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yuan, Tao, Yue Liu, Meijia Qian, et al.. (2025). Josephin Domain Containing 2 (JOSD2) inhibition as Pan-KRAS-mutation-targeting strategy for colorectal cancer. Nature Communications. 16(1). 3623–3623. 2 indexed citations
2.
Sheng, Xiangpeng, et al.. (2023). A pseudovirus-based method to dynamically mimic SARS-CoV-2-associated cell-to-cell fusion and transmission. Acta Biochimica et Biophysica Sinica. 55(11). 1840–1843. 1 indexed citations
3.
Sheng, Xiangpeng, Zhixiong Xia, Hanting Yang, & Ronggui Hu. (2023). The ubiquitin codes in cellular stress responses. Protein & Cell. 15(3). 157–190. 42 indexed citations
4.
Yang, Dejun, Dejun Yang, Dong Yang, et al.. (2022). Injectable, Self‐Healing and Multiple Responsive Histamine Modified Hyaluronic Acid Hydrogels with Potentialities in Drug Delivery, Antibacterial and Tissue Engineering. Macromolecular Rapid Communications. 44(3). e2200674–e2200674. 19 indexed citations
5.
Zhang, Zhiyuan, Qi Wu, Yu Liu, et al.. (2022). HERC3 directly targets RPL23A for ubiquitination degradation and further regulates Colorectal Cancer proliferation and the cell cycle. International Journal of Biological Sciences. 18(8). 3282–3297. 13 indexed citations
6.
Cao, Xu, Zijing Zhou, Ye Tian, et al.. (2021). Opposing roles of E3 ligases TRIM23 and TRIM21 in regulation of ion channel ANO1 protein levels. Journal of Biological Chemistry. 296. 100738–100738. 3 indexed citations
7.
Li, Chuanyin, Qingrun Li, Menghuan Zhang, et al.. (2021). MKRN3-mediated ubiquitination of Poly(A)-binding proteins modulates the stability and translation of GNRH1 mRNA in mammalian puberty. Nucleic Acids Research. 49(7). 3796–3813. 55 indexed citations
8.
Yuan, Shilin, Guanghong Liao, Menghuan Zhang, et al.. (2021). Translatomic profiling reveals novel self-restricting virus-host interactions during HBV infection. Journal of Hepatology. 75(1). 74–85. 22 indexed citations
9.
Ren, Jin, Yun Yang, Chuanyin Li, et al.. (2021). A Novel Prognostic Model of Early-Stage Lung Adenocarcinoma Integrating Methylation and Immune Biomarkers. Frontiers in Genetics. 11. 634634–634634. 21 indexed citations
10.
Liu, Fang, Hongyu Ding, Yun Yang, et al.. (2021). UBQLN4 is an ATM substrate that stabilizes the anti‐apoptotic proteins BCL2A1 and BCL2L10 in mesothelioma. Molecular Oncology. 15(12). 3738–3752. 8 indexed citations
11.
Li, Chuanyin, Rong Guo, Peng Chen, et al.. (2020). An Integrative Synthetic Biology Approach to Interrogating Cellular Ubiquitin and Ufm Signaling. International Journal of Molecular Sciences. 21(12). 4231–4231. 19 indexed citations
12.
Zhang, Tingting, Xiaoyü Ma, Junqi Wang, et al.. (2020). Clinical and molecular characterization of thirty Chinese patients with congenital lipoid adrenal hyperplasia. The Journal of Steroid Biochemistry and Molecular Biology. 206. 105788–105788. 6 indexed citations
13.
Chen, Yun, Lin Xu, Yun Yang, et al.. (2020). Screening for bacterial enzymes synthesizing GPR119 agonist in cAMP-responsive cells. Acta Biochimica et Biophysica Sinica. 53(1). 121–123. 3 indexed citations
14.
Xu, Yumin, Zhujun Cao, Ziqiang Li, et al.. (2019). Long Non-coding RNA NEAT1 Alleviates Acute-on-Chronic Liver Failure Through Blocking TRAF6 Mediated Inflammatory Response. Frontiers in Physiology. 10. 1503–1503. 16 indexed citations
15.
Hao, Zijian, Zhengwei Li, Qiu Li, et al.. (2019). Maternal exposure to triclosan constitutes a yet unrecognized risk factor for autism spectrum disorders. Cell Research. 29(10). 866–869. 27 indexed citations
16.
Meng, Xiangbo, Xiwei Liu, Xingdong Guo, et al.. (2018). FBXO38 mediates PD-1 ubiquitination and regulates anti-tumour immunity of T cells. Nature. 564(7734). 130–135. 208 indexed citations
17.
Lü, Wenli, et al.. (2018). A novel mutation in 5’-UTR of Makorin ring finger 3 gene associated with the familial precocious puberty. Acta Biochimica et Biophysica Sinica. 50(12). 1291–1293. 16 indexed citations
18.
Shen, Jiajia, Pengyu Li, Xuejing Shao, et al.. (2017). The E3 Ligase RING1 Targets p53 for Degradation and Promotes Cancer Cell Proliferation and Survival. Cancer Research. 78(2). 359–371. 51 indexed citations
19.
Li, Chuanyin, Xiaobo Gao, Kun Xia, et al.. (2017). Excessive UBE3A dosage impairs retinoic acid signaling and synaptic plasticity in autism spectrum disorders. Cell Research. 28(1). 48–68. 104 indexed citations
20.
Hu, Ronggui, Jun Sheng, Xin Qi, et al.. (2005). The N-end rule pathway as a nitric oxide sensor controlling the levels of multiple regulators. Nature. 437(7061). 981–986. 247 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026